Galapagos initiates clinical studies with GLPG0492, a candidate drug for cachexia
Galapagos initiates clinical studies with GLPG0492, a candidate drug for cachexia Mechelen, Belgium; 20 May 2010 – Galapagos NV (Euronext: GLPG) announced today that it…